Response-Adapted Treatment with Nivolumab and Brentuximab...

Clinical Lymphoma Myeloma and Leukemia 2019 / 09 Vol. 19

Response-Adapted Treatment with Nivolumab and Brentuximab Vedotin (BV) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): CheckMate 744 Subgroup Analyses

Kelly, Kara M., Daw, Stephen, Mauz-Körholz, Christine, Mascarin, Maurizio, Michel, Gerard, Cooper, Stacy, Beishuizen, Auke, Leger, Kasey J., Garaventa, Alberto, Buffardi, Salvatore, Brugières, Laurenc
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.271
Date:
September, 2019
File:
PDF, 69 KB
english, 2019
Conversion to is in progress
Conversion to is failed